Metastatic breast cancer patients who received an oral formulation of
Read moreHome »
Enzalutamide shows survival benefit in men with metastatic prostate cancer
A combination of enzalutamide and androgen deprivation therapy (ADT) significantly
Read moreFDA Approves Mektovi (binimetinib) and Braftovi (encorafenib) in Combination for Unresectable or Metastatic Melanoma with BRAF Mutations
On June 27, 2018, the Food and Drug Administration approved
Read more